Government Biotechnology Innovation Summit

DSI’s Inaugural Government Biotechnology Innovation Summit will offer a whole-of-government approach toward advancing innovative biotechnology and biomanufacturing solutions across agencies and sectors as a means of furthering and securing U.S. National Interests. Biotechnology for the government is the practical application of biological science technology to address specific objectives and challenges faced by government agencies at different levels. It involves harnessing the knowledge and tools of biology, genetics and other related disciplines to develop innovative solutions and strategies to tackle complex issues in sectors such as healthcare, agriculture, energy environment and national security. As the current global leader with a bioeconomy of 5% of GDP, it is imperative to continue discussions at this forum on innovation, application and secured funding for sustainable biotech evolution. In September 2022, the White House announced an Executive Order launching a National Biotechnology and Bio-manufacturing Initiative with a $2 billion funding plan to further drive a national strategy for expanding the domestic bioeconomy and biomanufacturing capacity.

The Government Biotechnology Innovation Summit will offer a forum for leaders to discuss how the government employs biotechnology for national security purposes, including biodefense initiatives, surveillance of infectious diseases, and the prevention and response to biological threats. The Summit will also explore investing in research and development, establishing regulations and guidelines, and collaborating with academia and industry to harness the potential of biotechnology for the benefit of society as a whole.